This is the authors' abstract. We don't add key points for this paper.
A synthetic strategy for accessing protoaculeine B (1), the N-terminal amino acid of the highly modified peptide toxin aculeine, was developed via the synthesis of the fully protected natural homologue of 1 with a 12-mer poly(propanediamine). The synthesis of mono(propanediamine) analog 2, as well as core amino acid 3, was demonstrated by this strategy. New amino acid 3 induced convulsions in mice; however, compound 2 showed no such activity.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shiozaki et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: